Multiple endocrine neoplasia type 2 CT: Difference between revisions

Jump to navigation Jump to search
Line 27: Line 27:
:* Tend to enhance more on the portal venous phase than the arterial phase
:* Tend to enhance more on the portal venous phase than the arterial phase
* 110 HU of enhancement on the arterial phase is compatible with [[pheochromocytoma]]; hypervascular [[metastases]] could be considered in an appropriate setting
* 110 HU of enhancement on the arterial phase is compatible with [[pheochromocytoma]]; hypervascular [[metastases]] could be considered in an appropriate setting
:* Up to 7% demonstrate areas of calcification<ref>{{cite book | last = Reiser | first = Maximilian | title = Magnetic resonance tomography | publisher = Springer | location = Berlin | year = 2008 | isbn = 354029354X }}</ref>
* It should be noted, that in patients with suspected [[pheochromocytoma]]s contrast may be contraindicated as it could precipitate a [[hypertensive crisis]].
* It should be noted, that in patients with suspected [[pheochromocytoma]]s contrast may be contraindicated as it could precipitate a [[hypertensive crisis]].
<gallery>
<gallery>

Revision as of 03:27, 5 October 2015

Multiple endocrine neoplasia type 2 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 2 from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Multiple endocrine neoplasia type 2 CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 2 CT

CDC on Multiple endocrine neoplasia type 2 CT

Multiple endocrine neoplasia type 2 CT in the news

Blogs on Multiple endocrine neoplasia type 2 CT

Directions to Hospitals Treating Multiple endocrine neoplasia type 2

Risk calculators and risk factors for Multiple endocrine neoplasia type 2 CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [5]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [6]

Overview

Neck CT scan may be helpful in the diagnosis of multiple endocrine neoplasia type 2. Findings on CT scan suggestive of multiple endocrine neoplasia type 2 include irregular dense calcific foci within thyroid.

CT

Medullary Thyroid Carcinoma

  • Both primary and metastatic lesions usually have irregular dense calcific foci within.[1]
  • In the chest, bullae formation and pulmonary fibrosis might happen as a result of a desmoplastic reaction.

Parathyroid Carcinoma

Enhancement on 4D-CT

  • On 4D-CT parathyroid adenomas typically demonstrate intense enhancement on arterial phase, washout of contrast on delayed phase and low attenuation on non-contrast imaging.
  • Secondary signs include the following:

Pheochromocytoma

  • CT is the first imaging modality to be used, with an overall sensitivity of 89%. This is on account of 98% of tumors being located within the abdomen and 90% limited to the adrenal glands.[3]
  • Usually large, heterogeneous masses with areas of necrosis and cystic change
  • They typically enhance avidly[4]
  • May wash out similar to an adrenal adenoma, but they tend to have greater enhancement in an arterial or portal venous contrast phase
  • Tend to enhance more on the portal venous phase than the arterial phase

References

  1. McCook TA, Putman CE, Dale JK, Wells SA (1982). "Review: Medullary carcinoma of the thyroid: radiographic features of a unique tumor". AJR Am J Roentgenol. 139 (1): 149–55. doi:10.2214/ajr.139.1.149. PMID 7046403.
  2. Johnson NA, Tublin ME, Ogilvie JB (2007). "Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism". AJR Am J Roentgenol. 188 (6): 1706–15. doi:10.2214/AJR.06.0938. PMID 17515397.
  3. Blake, Michael (2009). Adrenal imaging. Totowa, NJ: Humana Press. ISBN 193411586X.
  4. Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR; et al. (2004). "Pheochromocytoma: an imaging chameleon". Radiographics. 24 Suppl 1: S87–99. doi:10.1148/rg.24si045506. PMID 15486252.
  5. Image courtesy of Dr Paresh K Desai. Radiopaedia (original file[1]).Creative Commons BY-SA-NC
  6. Image courtesy of Dr Frank Gaillard. Radiopaedia (original file[2]).Creative Commons BY-SA-NC
  7. Image courtesy of Dr Roberto Schubert. Radiopaedia (original file[3]).Creative Commons BY-SA-NC
  8. Image courtesy of Dr Nafisa Shakir Batta. Radiopaedia (original file[4]).Creative Commons BY-SA-NC
  9. Shahnazari, Banafshe; Aghamaleki, Aria; Larijani, Bagher; Mohajeri Tehrani, Mohammad Reza; Rafati, Hasan; Babamahmoodi, Abdolreza (2012). "A Case of Multiple Endocrine Neoplasia Type 2B and Gangliomatosis of Gastrointestinal Tract". Case Reports in Medicine. 2012: 1–4. doi:10.1155/2012/491054. ISSN 1687-9627.

Template:WikiDoc Sources